324 Queen Street
Level 10
Brisbane, QLD 4000
Australia
61 13 0097 4621
https://microba.com
Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees:
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Dr. Luke Reid | Chief Executive Officer | 352.59k | N/A | N/A |
Prof. Gene Tyson | Co-Founder & Non-Executive Director | 103k | N/A | N/A |
Mr. James Heath | CFO & Joint Company Secretary | 255.85k | N/A | N/A |
Prof. Philip Hugenholtz | Co-Founder & Chair of Scientific Advisory Board | N/A | N/A | N/A |
Mr. Yao Liu | Chief Technology Officer | N/A | N/A | N/A |
Prof. Lutz Krause | Chief Scientific Officer | N/A | N/A | N/A |
Mr. Drew Webb | Chief Marketing Officer | N/A | N/A | N/A |
Prof. Trent Munro | Senior Vice President of Therapeutics | N/A | N/A | N/A |
Dr. Nicola Angel | Head of Laboratory Operations | N/A | N/A | N/A |
Mr. Bernie Woodcroft | Senior Vice President of Platform Solutions | N/A | N/A | N/A |
Microba Life Sciences Limited provides microbiome testing and analysis services for clinicians, consumers, and research customers in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, and Singapore. The company operates through two segments, Testing Services, and Research and Development. It offers pathology, therapeutics, and diagnostics services based on the human gut microbiome; testing and data analysis services for personal and research testing; and data-driven therapeutics platform that develops novel monoclonal microbial cell therapies for inflammatory bowel disease, cancer immunotherapy, and autoimmune diseases, as well as Databank for health and biome data. The company was incorporated in 2017 and is based in Brisbane, Australia.
Microba Life Sciences Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.